Table TDI-21. Gender ratio (ratio of males to females) among new and all clients entering outpatient treatment by primary drug (opioids, cannabis, cocaine, other stimulants) in 2004 for countries providing data – Part (ii) Among all clients entering outpatient treatment

Country

 

Opioids

Cocaine

Stimulants

Hypnotics, sedatives

Hallucinogens

Volatile inhalants

Cannabis

Other drugs

Base (known status)

Czech Republic

 

2.6

2.0

1.8

1.0

7.0

5.0

3.6

0.6

2138

Denmark

(1)

4.0

3.0

2.3

1.4

 

 

3.9

3.0

2776

Germany

 

3.5

5.7

3.1

0.8

3.0

1.5

5.9

4.0

44448

Greece

(2)

6.0

4.5

3.0

8.0

1.5

 

5.8

1.0

2371

Italy

 

6.5

12.9

4.8

1.7

17.1

7.0

15.0

1.7

132103

Cyprus

(3)

6.7

1.7

3.0

 

 

 

15.5

 

236

Hungary

 

3.1

6.9

2.5

0.6

3.7

3.9

7.0

7.0

9532

Malta

(4)

5.9

6.2

8.5

 

 

 

4.8

 

623

Netherlands

 

5.0

5.5

2.6

1.2

1.0

4.0

4.5

0.8

9887

Slovenia

(5)

3.7

2.8

1.7

 

 

 

2.9

 

1113

Slovakia

 

2.6

5.0

5.9

0.6

4.0

14.3

7.5

0.6

735

Finland

(6)

2.7

 

1.3

5.7

 

2.0

3.5

0.8

1442

Sweden

(7)

1.8

2.8

1.6

0.9

 

0.7

4.8

4.4

2192

United Kingdom

 

2.5

2.8

1.9

1.5

3.4

1.5

3.7

3.4

84737

Bulgaria

(8)

3.8

 

1.3

0.5

 

2.0

1.7

 

1435

 

 

 

 

 

 

 

 

 

 

 

Total

 

4.1

5.7

2.4

1.1

3.3

3.0

6.6

2.1

 

 

 

 

 

 

 

 

 

 

 

 

Total base

 

192656

26963

11891

5271

438

820

50109

7620

295768

Notes:

(1) No female cases for hallucinogens; no male cases for volatiles. 

(2) No female cases for volatiles.

(3) No cases for hypnotics, volatile inhalants and other drugs; no female cases for hallucinogens.

(4) No cases for hallucinogens, volatile inhalants and no male cases for other drugs; only 1 male case for hypnotics and no female cases.

(5) No cases for hallucinogens, volatile inhalants and other drugs; no female cases for hypnotics.

(6) No cases for cocaine and for volatiles 2 male cases and 1 female case; no male cases for hallucinogens and only 1 female case.

(7) 1 female case and no male cases for hallucinogens.

(8) No cases for cocaine, hallucinogens and other drugs; 2 male cases and no female cases for volatiles.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2005 Reitox national reports - TDI outpatient treatment centres

Data filter | tditab21b-en.xml